Microbot Medical
MBOT
26 hedge funds and large institutions have $5.49M invested in Microbot Medical in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
0.34% more ownership
Funds ownership: 10.62% → 10.96% (+0.34%)
8% less capital invested
Capital invested by funds: $6M → $5.49M (-$502K)
10% less funds holding
Funds holding: 29 → 26 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$302K |
| 2 |
BlackRock
New York
|
+$118K |
| 3 |
Morgan Stanley
New York
|
+$116K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$9.5K |
| 5 |
SIAP
Sterling Investment Advisors (Pennsylvania)
Berwyn,
Pennsylvania
|
+$7.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$318K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$81K |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.88K |
| 5 |
JP Morgan Chase
New York
|
-$3K |
MBOT Hedge Fund Activity: Q3 2021 in Review
26 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q3 2021, worth a combined $5.49M — down 8.4% from $6M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of MBOT and 1 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 6 added.
The largest buyer was Dimensional Fund Advisors, adding an estimated $302K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $318K sold.
- 26 institutional investors held Microbot Medical (MBOT) as of Q3 2021, down from 29 in Q2 2021.
- Funds reported $5.49M of Microbot Medical stock for Q3 2021, down 8.4% quarter-over-quarter.
- 1 fund opened new Microbot Medical positions in Q3 2021 and 4 closed out, a net change of -3 holders.
- The largest Microbot Medical buyer in Q3 2021 was Dimensional Fund Advisors, an estimated $302K added.
- The largest Microbot Medical seller in Q3 2021 was Renaissance Technologies, an estimated $318K sold.
Based on aggregated 13F filings for Q3 2021.